Shingrix
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Shingrix in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Shingrix.
33
Global Revenue Ranking
31
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Shingrix
More than 55 million people worldwide are currently living with the neurodegenerative disease
Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years
The infectious condition affects up to one in three people globally in their lifetimes
The unit will process the company’s vaccines, including Arexvy, Shingrix and Mosquirix
Approximately one in four people will develop shingles and the risk increases with age
ZOSTER-049 follows participants from two phase 3 trials for an additional six years
GSK’s vaccine business was up by 39% to £1.6bn thanks to the strong growth (46%) of its meningitis vaccine
Chief executive Emma Walmsley said results ‘reflect the anticipated impacts of COVID-19’
Pressure from COVID-19 restrictions leads to drug price increases
Turns priority to future growth drivers and R&D investment
Key Q3 drivers include Shingrix vaccine and asthma drug Nucala
Synflorix follow-up and influenza vaccine fail to make the cut
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology